share_log

Leerink Partners Maintains Market Perform on Progyny, Lowers Price Target to $21

Benzinga ·  Sep 19 21:09  · Ratings

Leerink Partners analyst Michael Cherny maintains Progyny (NASDAQ:PGNY) with a Market Perform and lowers the price target from $25 to $21.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment